Brendish, Nathan James <br/><br/>
Neisseria meningitidis serogroup B bivalent factor H binding protein vaccine.  [electronic resource] 

 -  Expert review of vaccines  Apr 2015 
 - 493-503 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-8395 
<br/><br/><label>Standard No.: </label>10.1586/14760584.2015.1015997  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Bacterial--immunology<br/>Bacterial Proteins--immunology<br/>Child<br/>Child, Preschool<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Drug Approval<br/>Europe--epidemiology<br/>Fever--chemically induced<br/>Humans<br/>Infant<br/>Meningococcal Infections--epidemiology<br/>Meningococcal Vaccines--adverse effects<br/>Middle Aged<br/>Neisseria meningitidis, Serogroup B--immunology<br/>Sepsis--epidemiology<br/>United States--epidemiology<br/>Young Adult